Pustuloderma during cutaneous lupus treatment with thalidomide.
Rúa-Figueroa
I
I
Erausquin
C
C
Naranjo
A
A
Carretero-Hernández
G
G
Rodriguez-Lozano
C
C
De la Rosa
P
P
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D003879:Dermatologic Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D005260:Female; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000188:drug therapy* / Q000473:pathology; D013492:Suppuration / Q000139:chemically induced / Q000473:pathology; D013792:Thalidomide / Q000009:adverse effects*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D003879:Dermatologic Agents; D013792:Thalidomide